Metro Inc
TSX:MRU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1.1), the stock would be worth CA$93.39 (2% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1 | CA$91.29 |
0%
|
| 3-Year Average | 1.1 | CA$93.39 |
+2%
|
| 5-Year Average | 1.1 | CA$92.54 |
+1%
|
| Industry Average | 1 | CA$91.28 |
0%
|
| Country Average | 2.9 | CA$254.66 |
+179%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
CA$23.3B
|
/ |
Mar 2026
CA$22.4B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2026
CA$23B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2027
CA$23.7B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2028
CA$24.6B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2029
CA$25.1B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2030
CA$26B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2031
CA$26.9B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2032
CA$27.8B
|
= |
|
|
CA$23.3B
|
/ |
Sep 2033
CA$28.7B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Metro Inc
TSX:MRU
|
19.2B CAD | 1 | 18.9 | |
| ZA |
S
|
Shoprite Holdings Ltd
JSE:SHP
|
151.4B ZAR | 0.7 | 20 | |
| CA |
|
Loblaw Companies Ltd
TSX:L
|
73.4B CAD | 1.3 | 27.2 | |
| CA |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
70.5B CAD | 0.8 | 18.2 | |
| UK |
|
Tesco PLC
LSE:TSCO
|
33.1B GBP | 0.6 | 18.1 | |
| US |
|
Kroger Co
NYSE:KR
|
43.2B USD | 0.4 | 42.2 | |
| NL |
|
Koninklijke Ahold Delhaize NV
AEX:AD
|
36.6B EUR | 0.5 | 16 | |
| AU |
|
Woolworths Group Ltd
ASX:WOW
|
46.3B AUD | 0.8 | 76.2 | |
| JP |
|
Seven & i Holdings Co Ltd
TSE:3382
|
4.9T JPY | 0.7 | 16.7 | |
| IN |
|
Avenue Supermarts Ltd
NSE:DMART
|
2.9T INR | 4.5 | 102.2 | |
| US |
|
Caseys General Stores Inc
NASDAQ:CASY
|
29.6B USD | 1.9 | 45.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.7 |
| Median | 2.9 |
| 70th Percentile | 5.7 |
| Max | 15 639 353.3 |
Other Multiples
Metro Inc
Glance View
Metro Inc., a stalwart in the Canadian retail landscape, navigates the competitive corridors of the grocery and pharmaceutical sectors with precision and acumen. Founded in 1947, Metro has grown from a humble beginning in Quebec to a significant force across the provinces, marking its presence with an expansive network of supermarkets, discount stores, and pharmacy outlets. The company's operations are neatly divided into two main segments: food and pharmaceuticals. Metro's grocery segment operates under well-recognized banners such as Metro, Super C, and Food Basics, offering a diverse array of products ranging from fresh produce and meats to private-label merchandise. This segment’s success hinges on Metro’s ability to adapt to consumer tastes and utilize data-driven strategies for inventory management, thereby optimizing both the customer shopping experience and logistical efficiency. Parallel to its grocery operations, Metro has built a robust pharmaceutical division through its affiliation with Jean Coutu and other pharmacy brands. This segment provides not only prescription medications but also a comprehensive suite of health, beauty, and wellness products. The synergy between the food and pharmaceutical divisions allows Metro to leverage cross-category shopping trends and customer loyalty programs, fostering a one-stop-shop format that resonates with its clientele. Revenue generation is anchored in the company's strategic pricing models, high-volume sales, and the continuous enhancement of private-label offerings, all orchestrated to maintain a balance between competitive pricing and profit margins. Through thoughtful expansions and acquisitions, Metro Inc. has crafted a diversified yet cohesive portfolio that drives sustainable growth and strengthens its positioning in the ever-evolving retail marketplace.